The first ever patient has been enrolled in the pivotal phase III clinical trial of a drug pioneered by Cardiff University which could bring hope for millions of shingles sufferers
New research suggests that patients recovering from bowel cancer surgery may be at a higher risk of relapse if their blood shows an immune response to a particular protein.
Researchers at the Cardiff Institute of Infection and Immunity have discovered one of the secrets of cytomegalovirus that allows this virus to persist within the salivary glands and subsequently disseminate through saliva
